Publications
Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response
He X, Wang Q, Cheng X, Wang W, Li Y, Nan Y, Wu J, Xiu B, Jiang T, Bergholz JS, Gu H, Chen F, Fan G, Sun L, Xie S, Zou J, Lin S, Wei Y, Lee J, Asara JM, Zhang K, Cantley LC, Zhao JJ. Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response. Cell. 2025 Feb 27:S0092-8674(25)00145-X. doi: 10.1016/j.cell.2025.01.043. Epub ahead of print. PMID: 40023152.
https://pubmed.ncbi.nlm.nih.gov/40023152/
PI3Kβ controls immune evasion in PTEN-deficient breast tumours
Bergholz JS*, Wang Q*, Wang Q*, Ramseier M, Prakadan S, Fang R, Kabraji S, Gray K, Abell-Hart K, Xie S, Guo X, Von T, Jiang T, Freeman G, Kim HJ, Shalek AK, Roberts TM, Zhao JJ. PI3Kβ controls immune evasion in PTEN-deficient breast tumours. Nature. 2023 May;617(7959):139-146. doi: 10.1038/s41586-023-05940-w. PMID: 37076617. PMCID: PMC10494520. *: Contributed equally
https://pubmed.ncbi.nlm.nih.gov/37076617/
STING Agonism Reprograms Tumor-associated Macrophages and Overcomes Resistance to PARP inhibition in BRCA1-deficient Models of Breast Cancer
Wang Q, Bergholz JS, Ding L, Lin Z, Kabraji SK, Hughes ME, He X, Xie S, Jiang T, Wang W, Zoeller JJ, Kim HJ, Roberts TM, Konstantinopoulos PA, Matulonis UA, Dillon DA, Winer EP, Lin NU, Zhao JJ. STING Agonism Reprograms Tumor-associated Macrophages and Overcomes Resistance to PARP inhibition in BRCA1-deficient Models of Breast Cancer. Nat Commun. 2022 May 31;13(1):3022. doi:10.1038/s41467-022-30568-1. PMID: 35641483; PMCID: PMC9156717.
https://pubmed.ncbi.nlm.nih.gov/35641483/
Targeting Oncogenic KRAS with Molecular Brush-Conjugated Antisense Oligonucleotides
Wang D*, Wang Q*, Wang Y, Chen P, Lu X, Jia F, Sun Y, Sun T, Zhang L, Che F, He J, Lian L, Morano G, Shen M, Ren M, Dong SS, Zhao JJ, Zhang K. Targeting Oncogenic KRAS with Molecular Brush-Conjugated Antisense Oligonucleotides. Proc Natl Acad Sci U S A. 2022 Jul 19;119(29): e2113180119. doi: 10.1073/pnas.2113180119. PMID: 35858356; PMCID: PMC9304022. *: Contributed equally
https://pubmed.ncbi.nlm.nih.gov/35858356/
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer
Ding L*, Kim HJ*, Wang Q*, Kearns M, Jiang T, Ohlson CE, Li BB, Xie S, Liu JF, Stover EH, Howitt BE, Bronson RT, Lazo S, Roberts TM, Freeman GJ, Konstantinopoulos PA, Matulonis UA, Zhao JJ. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018 Dec 11;25(11):2972-2980.e5. doi: 10.1016/j.celrep.2018.11.054. PMID: 30540933; PMCID: PMC6366450. *: Contributed equally
https://pubmed.ncbi.nlm.nih.gov/30540933/
Receptor-Interacting Protein Kinase 3 Contributes to Abdominal Aortic Aneurysms via Smooth Muscle Cell Necrosis and Inflammation.
Wang Q, Liu Z, Ren J, Morgan S, Assa C, Liu B. Receptor-Interacting Protein Kinase 3 Contributes to Abdominal Aortic Aneurysms via Smooth Muscle Cell Necrosis and Inflammation. Circ Res. 2015 Feb 13;116(4):600-11. doi: 10.1161/CIRCRESAHA.116.304899. PMID: 25563840; PMCID: PMC4329096.
https://pubmed.ncbi.nlm.nih.gov/25563840/
Complete List of Published Work in MyBibliography:
https://www.ncbi.nlm.nih.gov/myncbi/qiwei.wang.1/bibliography/public/